Group StrAteGiC report CorporAte GoverNANCe FiNANCiAl StAtemeNtS AND other iNFormAtioN Smith & Nephew ANNuAl report 2013 other FiNANCiAl iNFormAtioN 183 Index 2012 Financial highlights 164 Internal control framework 53 2013 Financial highlights 4 Inventories 59, 90, 118 Accounting Policies 101Investments 117 Accounts Presentation 184 Investment in associates 117, 118 Acquisitions and disposals 140 Investor information 168 Acquisition related costs 107 Key Performance Indicators 12 Advanced Surgical Devices segment performance 24 Leases 124, 142 Advanced Wound Management segment performance 29 Legal proceedings 130 American Depository Shares 169 Liquidity and capital resources 99 Articles of Association 177, 178 Manufacturing, supply and distribution 21, 157 Audit fees 107Marketplace 16 Board of Directors 44 New accounting standards 101 Business overview 19 Notes to the Company accounts 152 Business segment information 102 Notes to the Group Accounts 101 Cash and borrowings 121 Off-balance sheet arrangements 155 Chairmans statement 5 38, 95, Operating profit 103, 106 Chief Executive Officers review of strategy 10 Other finance costs income 108 Company auditors report 150 Outlook and trend information 15, 16 Company balance sheet 151 Parent Company accounts 151 Contingencies 129 Payables 120 Contractual obligations 163 People Employees 9, 22, 105 Corporate Governance Statement 48 Principal subsidiary undertakings 148 Critical accounting policies 90 Provisions 129 Cross Reference to Form 20-F 179 Property, plant and equipment 112, 155 Currency fluctuations 157 Receivables 60, 119 Currency translation 101 17, 20, 41, Deferred taxation 109 Regulation 158 Directors remuneration report 62 Related party transactions 147, 155 Directors responsibilities for the accounts 88 19, 95, Directors responsibility statement 89 Research and development 106, 164 Dividends 138 Restructuring and rationalisation expenses 107 Earnings per share 111 Retirement benefit obligation 59, 90, 131 Employees People 9, 22, 105 Risk factors 156 Employees Share Trust 138 Risk management 38, 61, 124 Executive Officers 46 Sales and marketing 22 Financial instruments 124 Selected financial data 159 Glossary of terms 181 Share based payments 143 Goodwill 114 Share buy-back 15, 138, 174 Governance and policy 43 52, 137, Share capital 154, 173 Group balance sheet 96 Shareholder return 83 Group cash flow statement 98 Strategy 10 Group history 155 Sustainability 34 Group income statement 94 Taxation 60, 95, 108 Group overview 8 Taxation information for Shareholders 175 Group statement of changes in equity 100 Treasury shares 138, 154 Group statement of comprehensive income 94 Independent auditors reports 91, 92, 93 Information for Shareholders 168 Intangible assets 115 Intellectual property 20 Interest 95, 108 Smith & Nephew ANNuAl report 2013 184 other fiNANciAl iNformAtioN About Smith & Nephew Special note regarding forward-looking statements the Smith & Nephew Group the Group is a global medical devices The Groups reports filed with, or furnished to, the US Securities and business operating in the markets for advanced surgical devices exchange commission Sec, including this document and written comprising orthopaedic reconstruction, trauma and sports medicine and information released, or oral statements made, to the public in the future advanced wound management, with revenue of approximately $4 billion by or on behalf of the Group, contain forward-looking statements within in 2013.
Smith & Nephew plc the company is the parent company of the meaning of the uS private Securities litigation reform Act of 1995, that the Group.
it is an english public limited company with its shares listed may or may not prove accurate.
for example, statements regarding onthe premium list of the UK Listing Authority and traded on the London expected revenue growth and trading profit margins discussed under Stock exchange.
Shares are also traded on the New York Stock exchange outlook, Global outlook and Strategic performance, market trends and in the form of American Depositary Shares ADSs.
our product pipeline are forward-looking statements.
phrases such as aim, plan, intend, anticipate, well-placed, believe, estimate, expect, this is the Annual report of Smith & Nephew plc for the year ended target, consider and similar expressions are generally intended to 31 December 2013. it comprises, in a single document, the Annual report identify forward-looking statements.
forward-looking statements involve and Accounts of the Company in accordance with UK requirements and known and unknown risks, uncertainties and other important factors that the Annual report on form 20-f in accordance with the regulations of could cause actual results, to differ materially from what is expressed or theUnited States Securities and Exchange Commission SEC.
Smith & Nephew operates on a worldwide basis and has distribution For Smith & Nephew, these factors include: economic and financial channels in over 90 countries.
in the more established countries by conditions in the markets we serve, especially those affecting health revenue, the Groups business operations are organised by divisions.
careproviders, payers and customers: price levels for established and Inthe majority of the remaining markets, operations are managed by innovative medical devices: developments in medical technology: country managers who are responsible for sales and distribution of the regulatory approvals, reimbursement decisions or other government Groups entire product range.
these comprise the emerging markets & actions: product defects or recalls: litigation relating to patent or other international markets.
claims: legal compliance risks and related investigative, remedial or Smith & Nephews corporate website, www.
com, gives enforcement actions: strategic actions, including acquisitions and additional information on the Group, including an electronic version of dispositions and our success in performing due diligence, valuing this Annual report.
information made available on this website, or other andintegrating acquired businesses: disruption that may result from websites mentioned in this Annual report, are not, and should not be transactions or other changes we make in our business plans or regarded as being, part of or incorporated into this Annual report.
organisation to adapt to market developments and numerous other matters that affect us or our markets, including those of a political, For the convenience of the reader, a Glossary of technical and financial economic, business, competitive or reputational nature: relationships terms used in this document is included on pages 181 to 182. the product withhealthcare professionals: reliance on information technology.
names referred to in this document are identified by use of capital letters Specific risks faced by the Group are described under Risk factors on and the symbol on first occurence and are trademarks owned by or pages 156 to 158 of this Annual report.
Any forward-looking statement is licensed to members of the Group.
based on information available to Smith & Nephew as of the date of the statement.
All written ororal forward-looking statements attributable to presentation Smith & Nephew are qualified by this caution.
Smith & Nephew does notundertake any obligation to update or revise any forward-looking The Groups fiscal year end is 31 December.
References in this Annual statement to reflect anychange in circumstances or in Smith & Report to a particular year are to the fiscal year unless otherwise Nephews expectations.
Except as the context otherwise requires, Ordinary Share orshare refer to the Ordinary Shares of Smith & Nephew plc of 20 US cents each.
Division data the Group Accounts of Smith & Nephew in this Annual report are Division data and division share estimates throughout this report are presented in uS Dollars.
Solely for the convenience of the reader, certain derived from a variety of sources including publicly available competitors parts of this Annual report contain translations of amounts in uS Dollars information, internal management information and independent market into Sterling at specified rates.
These translations should not be research reports.
construed as representations that the uS Dollar amounts actually represent such Sterling amounts or could be converted into Sterling Documents on display attherate indicated.
it is possible to read and copy documents referred to in this Annual unless stated otherwise, the translation of uS Dollars and cents to Report at the Registered Office of the Company.
Documents referred to in Sterling and pence in this Annual report has been made at the Bank of this Annual Report that have been filed with the Securities and Exchange england exchange rate on the date indicated.
on 24 february 2014, the commission in the uS may be read and copied at the Secs public Bank of england rate was uS$1.6631 per 1. reference room located at 450 fifth Street, Nw, washington Dc 20549. please call the Sec at 1-800-Sec-0330 for further information on the the results of the Group, as reported in uS Dollars, are affected by public reference rooms and their copy charges.
the Sec also maintains movements in exchange rates between uS Dollars and other currencies.
gov that contains reports and other information the Group applied the average exchange rates prevailing during the year regarding registrants that file electronically with the SEC.
This Annual to translate the results of companies with functional currency other than report and some of the other information submitted by the Group to the US Dollars.
The currencies which most influenced these translations in Sec may be accessed through the Sec website.
the years covered by this report were Sterling, Swiss franc and the euro.
the Accounts of the Group in this Annual report are presented in millions m unless otherwise indicated.
The inks used are renewable, biodegradable and emit fewer Volatile Organic Compounds VOCs than mineral-oil inks.
They are based on high levels of renewable raw materials such as vegetable oils and naturally occurring resin.
The inks do not contain any toxic heavy metals and therefore, do not pose a problem if placed in land ll.
